Evidence map›Paper›PMID 41084546›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025

Pericardial Effusion Post Hematopoietic Stem Cell Transplant: A Life-Threatening Complication with Myriad Causes.

Sidharth Totadri, Shobha Badiger, Pooja Mallya, Ravi Joshi, Deepika Tedakapalli, Sweta Mohanty, Sunil Bhat

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sidharth TotadriPediatric Hematology Oncology and Bone Marrow Transplant Unit, Bengaluru, India.
Shobha BadigerPediatric Hematology Oncology and Bone Marrow Transplant Unit, Bengaluru, India.
Pooja MallyaPediatric Hematology Oncology and Bone Marrow Transplant Unit, Bengaluru, India.
Ravi JoshiPediatric Hematology Oncology and Bone Marrow Transplant Unit, Bengaluru, India.
Deepika TedakapalliPediatric Cardiology, Mazumdar Shaw Medical Center, Bengaluru, India.
Sweta MohantyPediatric Cardiology, Mazumdar Shaw Medical Center, Bengaluru, India.
Sunil BhatPediatric Hematology Oncology and Bone Marrow Transplant Unit, Bengaluru, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pericardial effusion is an infrequent but life-threatening complication that occurs after hematopoietic stem cell transplant (HSCT). The present study aimed to analyze the etiology and outcome of patients who developed the entity. A retrospective analysis of patients who underwent allogeneic HSCT and developed symptomatic pericardial effusion between 2017 and 2023 was performed. Of 749 patients who underwent HSCT, 22 (3%) developed symptomatic pericardial effusion. The median age was 85 months (range: 26-252). The commonest indication for HSCT was transfusion-dependent thalassemia, which was more common than in patients who did not develop pericardial effusion (82% vs. 56%, Supplementary Information: The online version contains supplementary material available at 10.1007/s12288-024-01951-3.

Indexed as

Adenoviral infectionCalcineurin inhibitorPericardial tamponadeThrombotic microangiopathyVeno-occlusive disease

Identifiers

PMID41084546
PMCPMC12515182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.